Research and Markets: Drug Injection Devices to 2020: Key Therapeutic, Product, Market and Regulatory Factors

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/bj83lt/drug_injection) has announced the addition of the "Drug Injection Devices to 2020" report to their offering.

As new drugs become available for the treatment of an expanding list of health conditions, drug developers have increasingly pursued packaging and delivery options that simplify the administration process and increase the efficiency and reliability with which the drug can be introduced into the patient.

For injectable drugs, this pursuit has led to an accelerated evolution in injection device design, creating new opportunities and choices for drug designers and marketers. The injectable device sector today consists of a half-dozen established device classes and two emerging classes.

For the remainder of the decade, pipeline drugs and shifting demographics will drive sector growth as an aging population of baby boomers (23% of US population) provides stimulus for industry demand. Currently, the over 65 segment accounts for approximately 13% of the US population, with an estimated 40% of total healthcare expenditures, but by 2020, this segment is expected to grow to 17% of the population. This aging of the population will predominantly benefit products that can be used by the elderly.

This report examines the key therapeutic, product, market and regulatory factors for injection devices, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

- Analyzes and evaluates the shifting landscape for syringes and injection devices and assesses the market impact of new and evolving devices by therapeutic indication

- Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues

- Provides detailed descriptions of key injectable device therapeutic market segments, market demographics, and business strategies

- Forecasts syringe and injection device demand by indication and therapy to 2020

- Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

For more information visit http://www.researchandmarkets.com/research/bj83lt/drug_injection

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery